Cargando…
Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643481/ http://dx.doi.org/10.1186/1939-4551-6-S1-P162 |
| _version_ | 1782268315043889152 |
|---|---|
| author | Hafner, Roderick Peter Couroux, Peter Salapatek, Annemarie Hickey, Pascal Laidler, Paul Larché, Mark Patel, Deepen |
| author_facet | Hafner, Roderick Peter Couroux, Peter Salapatek, Annemarie Hickey, Pascal Laidler, Paul Larché, Mark Patel, Deepen |
| author_sort | Hafner, Roderick Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3643481 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | World Allergy Organization |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36434812013-05-09 Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses Hafner, Roderick Peter Couroux, Peter Salapatek, Annemarie Hickey, Pascal Laidler, Paul Larché, Mark Patel, Deepen World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643481/ http://dx.doi.org/10.1186/1939-4551-6-S1-P162 Text en Copyright ©2013 Hafner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Meeting Abstract Hafner, Roderick Peter Couroux, Peter Salapatek, Annemarie Hickey, Pascal Laidler, Paul Larché, Mark Patel, Deepen Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| title | Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| title_full | Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| title_fullStr | Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| title_full_unstemmed | Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| title_short | Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| title_sort | immunotherapy – 2080. fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643481/ http://dx.doi.org/10.1186/1939-4551-6-S1-P162 |
| work_keys_str_mv | AT hafnerroderickpeter immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses AT courouxpeter immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses AT salapatekannemarie immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses AT hickeypascal immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses AT laidlerpaul immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses AT larchemark immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses AT pateldeepen immunotherapy2080feld1derivedpeptideantigendesensitizationresultsinapersistenttreatmenteffectonsymptomsofcatallergy1yearafter4doses |